Skip to content
Low Dose GLP-1Providers

Research

Evidence-based research

Every claim tied to primary research or official labeling, with the human evidence graded per claim. Microdosing itself is off-label and unproven — a grade describes the specific claim, not the practice.

75 pieces, grouped by the question they answer rather than listed alphabetically: whether it works, how people do it, what it does to you, who it is different for, which drug and format, and what it costs.

75 articles

Does it actually work14

What the trials support, what is extrapolation from full-dose data, and where the honest answer is that nobody has tested it.

How people actually do it12

Dosing, titration, reconstitution, schedules and stopping. Mechanics rather than claims — and none of it a protocol.

Side effects and what to expect17

What a low dose does and does not reliably cause, symptom by symptom, and what the evidence behind each one is worth.

Specific conditions and situations9

Menopause, PCOS, insulin resistance, surgery, other medications — where the general answer stops being the right one.

The drugs and the formats11

Semaglutide, tirzepatide, retatrutide and the brand names — plus orals, sublinguals and pens, which is where a small dose is easiest to take.

Cost, legality and where to get it12

What it costs, what the compounding rules now are, and how the market prices a dose it mostly does not sell.